previous compound ID: 251 next compound
InChIKey: BLXXJMDCKKHMKV-UHFFFAOYSA-N
SMILES: CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "D Rotin" "J Goepp" "R Robert" "J Liao" "B Kus" "GW Carlile" "DY Thomas" "SD Macknight" "E Matthes"

chemical graph of compound 251





CID is 4409
synonyms found at PubChem are:
nabumetone, 42924-53-8, Relafen, Arthaxan, 4-(6-methoxynaphthalen-2-yl)butan-2-one, Nabumetona, Relifex, Listran, Relifen, nabumeton, Consolan, Mebutan, Balmox, Relif, 4-(6-Methoxy-2-naphthyl)-2-butanone, Dolsinal, Flambate, Nabumetonum, Unimetone, Prodac, Nabumetonum [INN-Latin], Nabuser, 4-(6-Methoxy-2-naphthalenyl)-2-butanone, UNII-LW0TIW155Z, BRL 14777, BRL-14777, MLS000069541, 2-Butanone, 4-(6-methoxy-2-naphthalenyl)-, BRN 2103472, LW0TIW155Z, SMR000058835, CHEBI:7443, BLXXJMDCKKHMKV-UHFFFAOYSA-N, NCGC00016853-01, 4-(2-Methoxynaphthalen-6-yl)butan-2-one, CAS-42924-53-8, DSSTox_CID_25472, DSSTox_RID_80901, DSSTox_GSID_45472, Nabucox, 4-[6-methoxy-2-naphthyl]-2-butanone, SR-01000759138, nabuton, CCRIS 8108, Nabumetone (oral), Nabumetone [USAN:BAN:INN:JAN], Relafen (TN), Nabumetone [USAN:USP:INN:BAN:JAN], Spectrum_001486, Opera_ID_765, Prestwick0_000909, Prestwick1_000909, Prestwick2_000909, Prestwick3_000909, Spectrum2_001969, Spectrum4_000174, Spectrum5_001286, 6-MNA (oral), Nobex, Nabumetone (oral), Nobex, D05CKR, AC1L1I3P, AC1Q4F4K, cid_4409, SCHEMBL2256, CHEMBL1070, BSPBio_000758, KBioGR_000687, KBioSS_001966, MLS001076325, BIDD:GT0104, DivK1c_000850, SPECTRUM1503650, SPBio_002097, SPBio_002957, Nabumetone, analytical standard, BPBio1_000834, GTPL7245, Nabumetone (JP17/USP/INN), DTXSID4045472, BDBM40128, CTK8B4843, HMS502K12, KBio1_000850, KBio2_001966, KBio2_004534, KBio2_007102, ZINC20221, NNB-001, NNB-004, NNB-005, MolPort-001-793-710, NINDS_000850, HMS1570F20, HMS1922G10, HMS2090D13, HMS2093I05, HMS2097F20, HMS2230H12, HMS3259I16, HMS3652M04, HMS3714F20, Pharmakon1600-01503650, BCP12152, HY-B0559, Tox21_110647, ANW-46490, CCG-39507, MFCD00079518, NSC758623, s4051, AKOS009529199, Tox21_110647_1, 4-(6-methoxy-2-naphthyl)butan-2-one, API0003472, CS-2669, DB00461, KS-1371, NC00579, NSC-758623, IDI1_000850, NCGC00016853-02, NCGC00016853-03, NCGC00016853-06, NCGC00095063-01, NCGC00095063-02, AC-19025, AJ-08410, AK-86115, BC966361, CC-32257, CPD000058835, LS-46825, M727, SAM002564225, SC-77045, ZB000767, SBI-0051869.P002, AX8142896, KB-238680, ST2405403, TC-135235, AB00052392, AM20040460, FT-0629765, D00425, AB00052392-13, AB00052392_14, AB00052392_15, 924N538, C-13097, SR-01000759138-2, SR-01000759138-3, BRD-K65146499-001-04-8, BRD-K65146499-001-14-7, Nabumetone, British Pharmacopoeia (BP) Reference Standard, Nabumetone, European Pharmacopoeia (EP) Reference Standard, Nabumetone, United States Pharmacopeia (USP) Reference Standard